Nilotinib significantly alters CSF biomarkers and increases endogenous dopamine in open label phase I clinical trial in Parkinso 医学讲坛 2022年06月01日 26 点赞 0 评论 917 浏览
Nilotinib improves motor skills, cognition and autonomic function in open label phase I Parkinson's disease with Dementia and Le 医学讲坛 2022年06月01日 53 点赞 0 评论 167 浏览
New Guidelines on Endovascular Treatment of Acute Ischemic Stroke Dawn of a New Era 医学讲坛 2022年06月01日 48 点赞 0 评论 349 浏览
